XML 34 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

Intangible Assets | 12 Months Ended
--- | ---
Sep. 30, 2025
Goodwill and Intangible Assets Disclosure [Abstract] |
Intangible Assets | Intangible Assets Intangible assets at September 30 consisted of:
| 2025 |  | 2024
(Millions of dollars) | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount |  | Gross Carrying Amount |  | Accumulated Amortization |  | Net Carrying Amount
Amortized intangible assets |  |  |  |  |  |  |  |  |  |  |
Developed technology | $ | 15,876 |  |  | $ | (9,225) |  |  | $ | 6,651 |  |  | $ | 15,827 |  |  | $ | (8,094) |  |  | $ | 7,733 |
Customer relationships | 5,522 |  |  | (3,291) |  |  | 2,231 |  |  | 5,513 |  |  | (2,878) |  |  | 2,635 |
Patents, trademarks and other | 1,251 |  |  | (745) |  |  | 507 |  |  | 1,185 |  |  | (682) |  |  | 503 |
Amortized intangible assets | $ | 22,649 |  |  | $ | (13,261) |  |  | $ | 9,389 |  |  | $ | 22,525 |  |  | $ | (11,654) |  |  | $ | 10,871 |
Unamortized intangible assets |  |  |  |  |  |  |  |  |  |  |
Acquired in-process research and development | $ | 14 |  |  |  |  |  |  | $ | 44 |  |  |  |  |
Trademarks | 2 |  |  |  |  |  |  | 2 |  |  |  |  |
Unamortized intangible assets | $ | 16 |  |  |  |  |  |  | $ | 46 |  |  |  |  |
Intangible amortization expense was $1.586 billion, $1.468 billion, and $1.465 billion in 2025, 2024 and 2023, respectively. The estimated aggregate amortization expense for the fiscal years ending September 30, 2026 to 2030 are as follows: 2026 — $1.538 billion; 2027 — $1.462 billion; 2028 — $1.370 billion; 2029 — $1.257 billion; 2030 — $904 million. The following is a reconciliation of goodwill by business segment:
(Millions of dollars) | Medical |  | Life Sciences |  | Interventional |  | Total
Goodwill as of September 30, 2023 | $ | 10,955 |  |  | $ | 897 |  |  | $ | 12,670 |  |  | $ | 24,522 |
Acquisitions (a) | 1,833 |  |  | — |  |  | — |  |  | 1,833 |
Currency translation | 43 |  |  | 7 |  |  | 59 |  |  | 109 |
Goodwill as of September 30, 2024 | $ | 12,832 |  |  | $ | 904 |  |  | $ | 12,729 |  |  | $ | 26,465 |
Acquisitions (b) | — |  |  | 4 |  |  | — |  |  | 4 |
Purchase price allocation adjustments | 67 |  |  | — |  |  | — |  |  | 67 |
Currency translation | 34 |  |  | 6 |  |  | 35 |  |  | 75 |
Goodwill as of September 30, 2025 | $ | 12,934 |  |  | $ | 914 |  |  | $ | 12,764 |  |  | $ | 26,612 |
(a)Represents goodwill recognized in the Medical segment upon the Company's acquisition of Advanced Patient Monitoring, which is further discussed in Note 11 (b)Represents goodwill recognized relative to a certain acquisition in fiscal year 2025, which was not material.

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-30/tableOfContent Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 350 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/350-20/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration